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protocol for a systematic review and network meta-analysis.
Abstract
Antibiotics are used in broiler poultry production both for the prevention and treatment of infectious
diseases. However, antibiotic use is a driver of antibiotic resistance. The World Health Organization has
published numerous reports urging all stakeholders concerned with both food-producing animals and
humans to establish recommended steps to enhance the prudent use of antimicrobials (WHO, 2015).
Similarly, the World Animal Health Organization has also published recommendations and position
statements regarding prudent use and risk management related to antimicrobial use in animals (OIE, 2017).
Colibacillosis is an important bacterial pathogen of poultry, and a costly disease for the industry resulting in
multimillion dollar losses annually through morbidity, mortality or carcass condemnation at slaughter.
Colibacillosis refers to any localized or systemic infection caused entirely or partly by the organism avian
pathogenic Escherichia coli (APEC). These bacteria may be isolated as the sole pathogen or contribute to a
disease complex with mixed viral and bacterial infections (Guabirara and Schouler, 2015). Two main disease
processes important in the broiler industry are early mortality and cellulitis. Early mortality is defined by
chicks under a week of age experiencing a higher than normal percentage of deaths in a flock. Early mortality
can be caused by many things, for example chilling, overheating, or dehydration, however E.coli infection, or
colibacillosis, is one of the main culprits. Colibacillosis can present with omphalitis, yolk sacculitis, enteritis,
pasty vents, pericarditis, perihepatitis, polyserositis, congested lungs, splenomegaly and darkened
proventriculus or any these combinations (Guabiraba and Schouler, 2015; Geetha and Palanivel, 2018). Many
chicks succumb to an early and severe infection or are culled due to excessive morbidity. Antibiotics are
typically used to reduce early mortality (Chauvin et al., 2005; Dziva and Stevens, 2008). Those with severe
infection are unlikely to survive, however appropriate treatment reduces transmission between birds and
improves the suitability of those with a mild infection. Not every labelled drug for E.coli is efficacious,
resistance is common (Kabir, 2010) and effectiveness can vary from flock to flock, even within a flock, with
more than one strain and more than one treatment.
Understanding the efficacy of antibiotics used to prevent colibacillosis in broiler chickens is essential to
optimizing their use; ineffective antibiotics should not be used for prevention or, if there are multiple
efficacious antibiotics, their importance to human medicine should be considered when making decisions on
antibiotic use. Systematic reviews of randomized controlled trials, and network meta-analysis to provide input
on relative antibiotic efficacy, will yield the highest level of evidence for efficacy of treatments under field
conditions (Sargeant and O’Connor, 2014).
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using	 the	 approach	 proposed	 by	 GRADE	 (GRADE,	 2015,	 Puhan	 et	 al.,	 2014),	 while	 also	
considering	the	nature	of	the	network	meta-analysis	 (Jansen	et	al.,	2011).	 	 If	 feasible,	we	will	
use	the	framework	from	the	CINeMA	platform	for	conveying	the	impact	of	risk	of	bias	on	the	
network	performance.				
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Discussion:		
	
This	systematic	review	will	provide	a	synthesis	of	the	current	evidence	regarding	the	efficacy	of	
antibiotics	used	to	prevent	collibacillosis	in	poultry.		Results	will	be	helpful	for	veterinarians	and	
poultry	producers	when	making	evidence-informed	decisions	regarding	treatment	options	to	
reduce	disease	and	mortality,	and	potentially	reduce	the	need	to	use	antibiotics	to	treat	
collibacillosis.		The	results	also	will	be	helpful	for	identifying	specific	gaps	in	knowledge	related	
to	the	efficacy	of	prophylactic	antibiotics	for	collibacillosis	to	target	additional	research.	
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Appendix	1:		Antibiotics	approved	for	use	for	collibacillosis	in	poultry,	with	trade	names	and	
labelling	information.	
	
	
Antibiotic	
(AVIAN)	 Market	name		 Dose		
	 	 	
Amoxicillin	
Paracillin®	SP	(Pr)	(Merck	Animal	
Health),	Amoxicillin	SP	(Pr)	(Bio	
Agri	Mix)		
10-20	mg	(8-16	mg	amoxicillin	
trihydrate)/kg	b.w.	daily,	for	3-5	
consecutive	days.		
Avilamycin	
Paracillin®	SP	(Pr)	(Merck	Animal	
Health),	Amoxicillin	SP	(Pr)	(Bio	
Agri	Mix)		
0.15-0.3	kg/1,000	kg	feed	(15-30	
ppm	avilamycin).	Feed	as	sole	
ration	for	21d	during	risk	period	
Bacitracin	
Paracillin®	SP	(Pr)	(Merck	Animal	
Health),Amoxicillin	SP	(Pr)	(Bio	
Agri	Mix)		
Broilers:	0.5	kg/999.5	kg	
complete	feed	(55	mg/kg).	Feed	
continuously	to	market	weight.	
Ceftiofur	
(sodium)	
Paracillin®	SP	(Pr)	(Merck	Animal	
Health),Amoxicillin	SP	(Pr)	(Bio	
Agri	Mix)		
Day-old	chicks:	0.08-0.2	mg	
ceftiofur/chick	in	the	neck.	One	
mL	of	50	mg/mL	reconstituted	
solution	will	treat	~250-625	day-
old	chicks.	
Chlortetracycline	
Paracillin®	SP	(Pr)	(Merck	Animal	
Health),Amoxicillin	SP	(Pr)	(Bio	
Agri	Mix)		
Broiler,	layer	and	replacement	
chickens:	Add	1	kg/tonne	[110	
mg/kg	(0.011%)]	of	complete	
feed.		
Feed	continuously	as	sole	ration	
from	onset	of	symptoms	for	at	
least	one	month	or	until	a	few	
days	after	symptoms	disappear.	
Gentamicin	 Garasol®	Injection	(100	mg/mL)	(Intervet/Merck	Animal	Health)	
Each	day-old	chick:	Inject	S.C.	in	
neck	with	0.2	mg	gentamicin	in	a	
0.2	mL	dose	(diluted	with	saline	
solution).	
	
Coccivac®-B52	(Intervet/Merck	
Animal	Health)	
Healthy	birds	1d	of	age:	Spray	
cabinet:	Dilute	1,000	dose	vial	
with	210	mL	distilled	water.	
Each	box	of	100	chicks	receives	
21	mL	of	vaccine	solution.	
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Lincomycin	
(hyrdrochloride)	
	
	
	
	
	
	
Lincomycin	Hydrochloride	Soluble	
Powder	(Rx)	(Huvepharma)	
	
	
	
	
	
	
Broilers:	64	mg	lincomycin/gal	
drinking	water	for	7d.	
	
	
Lincosol	Soluble	Powder	(Rx)	
(Med-Pharmex)	
Broilers:	64	mg	lincomycin/gal	
drinking	water	for	7d.		
	
Lincomycin	Soluble	Powder	(Bio	
Agri	Mix)	
1	jar/2,000	L	drinking	water	(16	
mg	antibiotic	activity/L).		
	 Lincomix®	Soluble	Powder	(Zoetis)	
At	first	sign	of	disease,	
administer	at	following	dosage	
as	sole	source	of	drinking	water	
for	7	consecutive	days.80	g	
soluble	powder	will	medicate	
2,000	L	water	or	1	level	scoop	
(4.7	g)/120	L	water	(16	mg	
antibiotic	activity/L).Stock	
solution:	80	g/8	L	(1	level	
scoop/470	mL)	water	in	a	clean	
glass	or	plastic	container,	mix,	
and	dispense	1	L	stock	
solution/250	L	drinking	water.	
	
	
	
	
	
	
	
	
Neomycin	
(sulfate)	
	
Neomycin	325	(Pr)	(Vetoquinol)	
	
	
	
	
Flock	treatment:	As	soon	as	
symptoms	are	observed,	give	for	
3-5d.	
Day-old	to	2	weeks:	20	g	
powder/225	L	water	OR	100	g	
powder	(1	pouch)/1,125	L	
water.		
2	weeks	to	adulthood:	40	g	
powder/225	L	water	OR	200	g	
powder	(2	pouches)/1,125	L	
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water.	
	 Neo-Chlor®	(Pr)	(Vetoquinol),		
100	g,	10	kg	sizes:	Dissolve	100-
200	g	(1-2	pouches)	powder/225	
L	water	for	3-5d.		
400	g:	Dissolve	400-800	g	(1-2	
pouches)/900	L	water	for	3-5d.		
Automatic	proportioner:	Set	to	
distribute	30	mL/4	L	water	(1	
oz/gal).	Prepare	stock	solution	
by	dissolving	400-800	g	(1-2	
pouches)/6.75	L	water	to	
medicate	900	L	water.	
	 Neo-Tetramed	(Medprodex)	
Dissolve	400-800	g	(1-2	
pouches)/900	L	water	for	3-5d.		
	 NeoMed	325	(Medprodex)	
Day-old	to	2	weeks:	20	g/225	L	
of	water	OR	100	g/1,125	L	of	
water.	2	weeks	to	adulthood:	40	
g/225	L	of	water	OR	200	g/1,125	
L	of	water.		
	
Neotet	Soluble	Concentrate	
(Dominion)	
100	g	in	200-400	L	of	drinking	
water	for	3d.		
Oxytetracycline	 Oxy	250	(Medprodex)	 1	g/5	L	water	OR	100	g/500	L	
drinking	water	for	3-5d.		
	 Oxysol-62.5	(Pr)	(Vetoquinol)	
Dissolve	4	g	powder/5	L	water	
OR	400	g	(1	pouch)	powder/500	
L	drinking	water	and	give	for	3-
5d.	
Oxytetracycline	
HCI	
Oxytetracycline	HCI	Soluble	
Powder	1000	(Bio	Agri	Mix)	
100	g/1,350	L	drinking	water	for	
3-4d.		
Salinomycin	
(sodium)	
	
	
	
Sacox®	60	(Huvepharma),	Bio-
Cox®	60	Granular	(Huvepharma)	
	
	
	
Broiler,	roaster	and	replacement	
(breeder	and	layer)	chickens:		
40-60	g/ton	(0.0044-0.0066%).	
Feed	continuously	as	sole	ration.	
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Salinomycin	60	Premix	(Bio	Agri	
Mix),	Posistac®	6%	Premix	
(Phibro),	Coxistac®	6%	Premix	
(Phibro)	
Thoroughly	mix	1000	g	(1.0	kg)	
Salinomycin	60	Premix	with	999	
kg	complete	feed	to	obtain	a	
finished	feed	containing	60	
mg/kg	(60	ppm)	salinomycin	
sodium.	Feed	continuously	as	
sole	ration	up	until	slaughter.	
	
Coxistac®	12%	Granular	(Phibro),	
Sacox®	120	(Huvepharma	AD)	
Broiler	chickens:	Thoroughly	mix	
500	g	Coxistac	12%	Granular	
with	1,000	kg	complete	feed	to	
obtain	a	medicated	feed	with	a	
salinomycin	sodium	
concentration	of	0.0060%	(60	
mg/kg).	Can	be	prepared	in	the	
form	of	meal	or	pellets.	Feed	
continuously	as	sole	ration	up	to	
marketing.	
Sulfadimethoxine	
Sulfadimethoxine	Concentrated	
Solution	12.5%	(Rx)	(VetOne),	
Sulforal	(Rx)	(Med-Pharmex),	
Sulfadived™	12.5%	Solution	(Rx)	
(Vedco),	Di-Methox®	
Concentrated	Solution	12.5%	(Rx)	
(AgriLabs)	
Use	0.05%	concentration.		
Add	1	oz	(30	mL)	to	2	gal	water	
or	25	oz/50	gal	water.		
Treat	for	6	consecutive	days.		
	
Sulfadimethoxine	107g	Powder	
(Rx)	(VetOne),	Di-Methox®	Soluble	
Powder	(Rx)	(AgriLabs),	Sulfasol	
(Rx)	(Med-Pharmex),	Sulfasol	(Rx)	
(Med-Pharmex)	
Use	0.05%	concentration.		
Add	1	packet/50	gal	water.		
Treat	for	6	consecutive	days.		
Stock	solution:	Add	5	packets/2	
gal	water.		
Sulfaquinoxaline	 Sulfaquinoxaline	19.2%	Liquid	Concentrate	(Dominion)	
https://cdmv.cvpservice.com/pr
oduct/view/1181072?key=dosag
e	
Tetracycline	
Onycin	1000	(Pr)	(Vetoquinol),	
Tetra	1000	(Dominion),	Tetramed	
250	and	1000	(Medprodex),	Oxy	
250	(Medprodex)	
1	g/20	L	of	water	OR	100	g/2000	
L	of	drinking	water,	for	3-5d.	For	
automatic	proportioner:	Set	to	
distribute	30	mL/4	L	drinking	
water	(1	oz/gal	U.S.).	Prepare	
stock	solution	by	dissolving	25	g	
powder/4	L	water.	This	will	
medicate	500	L	drinking	water.	
	
Oxytetracycline	HCI	Soluble	
Powder	1000	(Bio	Agri	Mix)	
100	g/1,350	L	drinking	water	for	
3-4d.		
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	 Tetracycline	250	(Vetoquinol)	
400	g:	Dissolve	1	g/5	L	or	400	g	
(1	pouch)/2,000	L	drinking	
water,	for	3-5d.		
10	kg:	Dissolve	1	g/5	L	or	100	
g/500	L	drinking	water,	for	3-5d.		
	
	
	
Oxysol-62.5	(Pr)	(Vetoquinol)	
	
	
Dissolve	4	g	powder/5	L	water	
OR	400	g	(1	pouch)	powder/500	
L	drinking	water	and	give	for	3-
5d	
Tylosin	(tartrate)	
	
	
	
Tylan®	Soluble	(Rx)	(Elanco)	
	
	
	
broiler	chickens:	851-1,419	
mg/gal	(225-375	ppm)	in	
drinking	water.	Administer	
medicated	drinking	water	for	a	
single	5d	period.	
Broiler	chickens:	100-150	mg/L,	
depending	on	severity	of	
infection.		
	
	
	
Tylosin	Soluble	Powder	(Bio	Agri	
Mix)	
Mix	0.4-
0.6g/4L	
water,	Treat	
5d	
	
Tylan™	Soluble	(Pr)	(Elanco	
(Novartis))	
	
Broiler	chickens	(drinking	
water):	Treat	for	5d	at	not	<100	
mg/L	(0.4	g/4	L)	and	not	more	
than	150	mg/L	(0.6	g/4	L)	
depending	on	severity	of	
outbreak.		
	
	
Tylosin	
(Phosphate)	
	
	
Tylosin	40	(Bio	Agri	Mix)	
	
	
125	kg/tonne	complete	diet	(11	
g	tylosin).		
	
Tylan™	100	Premix	(Pr)	(Elanco	
(Novartis))	
Broiler	chickens:	0.91	kg	(200	g	
tylosin)/tonne	complete	feed.		
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Virginiamycin	
	
	
	
	
	
Virginiamycin	44	Premix	(Bio	Agri	
Mix),	Stafac®	44	(Phibro)	
	
Broilers:	Mix	0.5	kg	(22	g	
virginiamycin)/tonne	complete	
feed	to	provide	1	mg/kg	
b.w./day.	Feed	continuously	as	
sole	ration	from	weaning	to	
market	weight.	
	 Stafac®	22	(Phibro)	
Broilers:	Mix	1	kg	(22	g	
virginiamycin)/tonne	complete	
feed	to	provide	1	mg/kg	
b.w./day.	Feed	continuously	as	
sole	ration	from	day	1	to	market	
weight.	
	
Stafac®	500	(Phibro)	
Mix	44	g/tonne	(22	g	
virginiamycin)	complete	feed.	
This	will	provide	1	mg/kg	
b.w./day.		
	
